Bupropion Hydrochloride
- Product NDC
- 71335-1837
- 11-digit product format
- 713351837
- Labeler code
- 71335
- Product ID
- 71335-1837_baf029ae-b819-465b-82e9-82167b132b79
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA211347
- Marketing category
- ANDA
- Marketing start
- 2020-11-02
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bupropion Hydrochloride
- Brand name suffix
- SR
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUPROPION HYDROCHLORIDE | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | ZG7E5POY8O |
| Rxcui | 993518 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-1837-1 | Bupropion HydrochlorideSR | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 106 |
| 71335-1837-2 | Bupropion HydrochlorideSR | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | | 106 |
| 71335-1837-3 | Bupropion HydrochlorideSR | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 106 |
| 71335-1837-4 | Bupropion HydrochlorideSR | 120 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 120 | | 106 |
| 71335-1837-5 | Bupropion HydrochlorideSR | 45 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 45 | | 106 |
| 71335-1837-6 | Bupropion HydrochlorideSR | 180 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 180 | | 106 |
| 71335-1837-7 | Bupropion HydrochlorideSR | 28 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 28 | | 106 |
| 71335-1837-8 | Bupropion HydrochlorideSR | 56 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 56 | | 106 |
| 71335-1837-9 | Bupropion HydrochlorideSR | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 106 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-1837 | BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 106 | Current NDC, Legacy NDC, 9 package rows | 20240726_0574b84d-075f-410f-a8eb-86901e307ea2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1837-1 | 71335183701 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-1) | 2021-05-05 | 0000-00-00 | No | No | Current |
| 71335-1837-2 | 71335183702 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-2) | 2022-02-17 | 0000-00-00 | No | No | Current |
| 71335-1837-3 | 71335183703 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-3) | 2021-04-26 | 0000-00-00 | No | No | Current |
| 71335-1837-4 | 71335183704 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-4) | 2024-07-17 | 0000-00-00 | No | No | Current |
| 71335-1837-5 | 71335183705 | 45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-5) | 2024-07-17 | 0000-00-00 | No | No | Current |
| 71335-1837-6 | 71335183706 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-6) | 2022-02-02 | 0000-00-00 | No | No | Current |
| 71335-1837-7 | 71335183707 | 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-7) | 2024-07-17 | 0000-00-00 | No | No | Current |
| 71335-1837-8 | 71335183708 | 56 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-8) | 2024-07-17 | 0000-00-00 | No | No | Current |
| 71335-1837-9 | 71335183709 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-9) | 2024-07-17 | 0000-00-00 | No | No | Current |